Nanotechnology Commercialization Conference announces keynote lineup

(Nanowerk News) Global technology leaders will descend upon North Carolina for the Nanotech Commercialization Conference (NCC), hosted by the Center of Innovation for Nanobiotechnology (COIN), the NanoBusiness Commercialization Association (NanoBCA) and the North Carolina Office of Science & Technology. Corporate, investor, start-up and academic leaders will all be in attendance at this cutting edge event in Durham, NC, April 4th-5th, 2012.
Nanotechnology is rapidly transforming industries from medicine to manufacturing to energy. Since the passage of the 21st Century Nanotechnology R&D Act, the U.S. has spent $24 billion in the science of nanotechnology. The science is rapidly becoming the business of nanotechnology, creating thousands of new start-ups, bolstering nearly every industry across the globe, and bringing life changing innovations to market that already improve lives around the world.
"We are honored to host an event of this caliber in North Carolina, which is attracting nanotech leaders from around the globe. It reflects the growing awareness of and interest in North Carolina's world-class nanotech cluster," said Griffith Kundahl, Executive Director of COIN.
Topics to be addressed during the conference sessions include:
  • Risk vs. Value: Impact of Nanotechnology Environmental, Health, Safety (EHS) on Business Decisions
  • Achieving Commercialization Success: How to Sell Nano Products to Large Companies
  • Nano Energy Solutions: Perspectives on Solar, Wind and Batteries
  • The Current State of Investing in the Nanotechnology Community
  • Nanotechnology Industrial Espionage – How to Protect Your Company
  • Nanomanufacturing Panel
  • Cybersecurity Breakout Session
  • A complete conference agenda can be found here -
    "We have assembled a tremendous lineup of keynote speakers for our premier event, which has already become the largest Nanotechnology conference in the South," said Vincent Caprio, Executive Director of the NanoBCA.
    The conference will feature a dynamic lineup of keynote speakers, including:
  • Sally Tinkle, PhD, Acting Director & EHS Coordinator, NNCO
  • Richard Ridgley, Chief Scientist at the National Reconnaissance Office
  • James M. Hussey, CEO, NanoInk
  • Scott Livingston, Chairman & CEO, Livingston Securities
  • Scott Rickert, President, Co-Founder & CEO, NanoFilm
  • Douglas W. Jamison, Chairman of the Board, CEO & Managing Director, Harris & Harris Group
  • Jim Phillips, Chariman & CEO, NanoMech
  • Frank M. Torti, MD, MPH, FACP, VP Strategic Programs/Director, Comprehensive Cancer Center & Chair, Department of Cancer Biology, Wake Forest Baptist Medical Center
  • David F. Williams, Ph.D., Professor, Wake Forest Institute for Regenerative Medicine
  • In addition, the Nanotech Commercialization Conference has been structured to facilitate networking with fellow professionals, and keeping up with the cutting edge of nano. The event will be held in the historic Bay 7 Meeting and Event Facility at the American Tobacco Campus, 318 Blackwell Street, Durham, North Carolina 27701.
    Sponsors for the NCC include: Joint School of Nanoscience & Nanoengineering (JSNN), Kymanox, RTI International, Carlyle & Conlan, Gateway University Research Park, Poyner Spruill, MBHB, UNC Charlotte, Charlotte Research Institute, Nanoscale Science, Zeiss, CMG Partners, Prasidiux, Electricities, Wyrick Robbins, Square 1 Bank, East Carolina University, Research Triangle Region, BLNC. This is a partial list of Sponsors. Click here for a complete list.
    For more information on the Nanotech Commercialization Conference, see: For those interested in speaking at this groundbreaking event, please contact Vincent Caprio at [email protected]. For sponsorship inquiries, please contact Jim Roberts at [email protected].
    About the NanoBCA
    The NanoBusiness Commercialization Association was founded in 2001 as the "NanoBusiness Alliance," the first nonprofit association focused on the commercialization of nanotechnologies. Through its extensive network of leading start-ups, Fortune 500 companies, research institutions, non-governmental organizations and public-private partnerships, the Association shapes national nanotechnology policy and helps accelerate the commercialization of nanotechnology innovations. The NanoBusiness Commercialization Association is based in Washington, D.C. and Shelton, CT.
    About COIN
    Established in 2009, COIN is a nonprofit, virtual center of innovation for nanobiotechnology and nanomedicine based in North Carolina. COIN supports those organizations that are most-impacted by the convergence of nano (advanced materials) and bio (life sciences) by ensuring that they have immediate structured access to all relevant resources and a conduit to key regulatory agencies impacting the field. COIN is a premier source of networking opportunities, information, and tailored innovation services that address client needs and catalyze and advance commercialization of nanobiotechnology. Through a network of academic and emerging company researchers, COIN provides access to a myriad of nano-biotechnologies that may be applied across a range of life science sectors. COIN provides a single point of entry to the nanobiotechnology community, connecting key players at the intersection of advanced materials and life sciences.
    Source: NanoBCA